Evaluation of Diabetic Foot Ulcer Healing With Hyperspectral Imaging of Oxyhemoglobin and Deoxyhemoglobin

OBJECTIVE Foot ulceration remains a major health problem for diabetic patients and has a major impact on the cost of diabetes treatment. We tested a hyperspectral imaging technology that quantifies cutaneous tissue hemoglobin oxygenation and generated anatomically relevant tissue oxygenation maps to assess the healing potential of diabetic foot ulcers (DFUs). RESEARCH DESIGN AND METHODS A prospective single-arm blinded study was completed in which 66 patients with type 1 and type 2 diabetes were enrolled and followed over a 24-week period. Clinical, medical, and diabetes histories were collected. Transcutaneous oxygen tension was measured at the ankles. Superficial tissue oxyhemoglobin (oxy) and deoxyhemoglobin (deoxy) were measured with hyperspectral imaging from intact tissue bordering the ulcer. A healing index derived from oxy and deoxy values was used to assess the potential for healing. RESULTS Fifty-four patients with 73 ulcers completed the study; at 24 weeks, 54 ulcers healed while 19 ulcers did not heal. When using the healing index to predict healing, the sensitivity was 80% (43 of 54), the specificity was 74% (14 of 19), and the positive predictive value was 90% (43 of 48). The sensitivity, specificity, and positive predictive values increased to 86, 88, and 96%, respectively, when removing three false-positive osteomyelitis cases and four false-negative cases due to measurements on a callus. The results indicate that cutaneous tissue oxygenation correlates with wound healing in diabetic patients. CONCLUSIONS Hyperspectral imaging of tissue oxy and deoxy may predict the healing of DFUs with high sensitivity and specificity based on information obtained from a single visit.

[1]  R. Kahn.  Report and Recommendations of the San Antonio Conference on Diabetic Neuropathy , 1988, Diabetes Care.

[2]  G. Reiber,et al.  Pathways to Diabetic Limb Amputation: Basis for Prevention , 1990, Diabetes Care.

[3]  G. Reiber,et al.  Lower extremity foot ulcers and amputations in diabetes , 1995 .

[4]  K. Alberti.  Impaired glucose tolerance--fact or fiction. , 1996, Diabetic medicine : a journal of the British Diabetic Association.

[5]  M. Fantone,et al.  Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.

[6]  D G Smith,et al.  Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings. , 1999, Diabetes care.

[7]  R. Reneman,et al.  Prediction of imminent amputation in patients with non-reconstructible leg ischemia by means of microcirculatory investigations. , 1999, Journal of vascular surgery.

[8]  E H Wagner,et al.  Incidence, outcomes, and cost of foot ulcers in patients with diabetes. , 1999, Diabetes care.

[9]  D. Armstrong,et al.  Screening techniques to identify people at high risk for diabetic foot ulceration: a prospective multicenter trial. , 2000, Diabetes care.

[10]  C Harrington,et al.  A cost analysis of diabetic lower-extremity ulcers. , 2000, Diabetes care.

[11]  Annemarie A. Edwards,et al.  Diabetic foot disorders: A clinical practice guideline , 2000 .

[12]  B. Sumpio.  Primary care: Foot ulcers , 2000 .

[13]  D. Armstrong,et al.  Diabetic foot disorders: a clinical practice guideline. American College of Foot and Ankle Surgeons. , 2000, The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons.

[14]  M. Pfohl,et al.  Early detection of microcirculatory impairment in diabetic patients with foot at risk. , 2001, Diabetes care.

[15]  D. Claremont,et al.  Noninvasive Measurement Techniques for Monitoring of Microvascular Function in the Diabetic Foot , 2002, The international journal of lower extremity wounds.

[16]  K. Zuzak,et al.  Visible reflectance hyperspectral imaging: characterization of a noninvasive, in vivo system for determining tissue perfusion. , 2002, Analytical chemistry.

[17]  J. Griffiths,et al.  The North‐West Diabetes Foot Care Study: incidence of, and risk factors for, new diabetic foot ulceration in a community‐based patient cohort , 2002, Diabetic medicine : a journal of the British Diabetic Association.

[18]  R. Frykberg,et al.  Diabetic foot ulcers: pathogenesis and management. , 2002, American family physician.

[19]  P. Raskin,et al.  Report of the expert committee on the diagnosis and classification of diabetes mellitus. , 1999, Diabetes care.

[20]  Stefan Beckert,et al.  The impact of the Micro-Lightguide O2C for the quantification of tissue ischemia in diabetic foot ulcers. , 2004, Diabetes care.

[21]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[22]  Marie-Line Barbet.  [Foot ulcers]. , 2005, Revue de l'infirmiere.

[23]  Thomas E. Lyons,et al.  The Use of Medical Hyperspectral Technology to Evaluate Microcirculatory Changes in Diabetic Foot Ulcers and Predict Clinical Outcomes Received for publication 26 October 2006 and accepted in revised form 8 January 2007. Short title: Hyperspectral Technology in Diabetic Foot Ulceration , 2007 .

[24]  Michael J. Mueller,et al.  Comprehensive Foot Examination and Risk Assessment , 2008, Diabetes Care.

[25]  Richard Hellman,et al.  Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. , 2008, Physical therapy.

[26]  J. Richard,et al.  [Epidemiology of diabetic foot problems]. , 2008, La Revue de medecine interne.

[27]  L. Melton,et al.  Peripheral Vascular Disease and Diabetes , 2022 .